JPH04169187A - Simultaneous fermentative production of neutral amino acid and glutamic acid - Google Patents
Simultaneous fermentative production of neutral amino acid and glutamic acidInfo
- Publication number
- JPH04169187A JPH04169187A JP29840690A JP29840690A JPH04169187A JP H04169187 A JPH04169187 A JP H04169187A JP 29840690 A JP29840690 A JP 29840690A JP 29840690 A JP29840690 A JP 29840690A JP H04169187 A JPH04169187 A JP H04169187A
- Authority
- JP
- Japan
- Prior art keywords
- neutral amino
- surfactant
- medium
- amino acids
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 title claims abstract description 35
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 27
- 230000007935 neutral effect Effects 0.000 title claims abstract description 17
- 238000012262 fermentative production Methods 0.000 title abstract 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 title description 23
- 235000001014 amino acid Nutrition 0.000 title description 23
- 235000013922 glutamic acid Nutrition 0.000 title description 5
- 239000004220 glutamic acid Substances 0.000 title description 5
- 229940024606 amino acid Drugs 0.000 claims abstract description 26
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 10
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 10
- 241000186146 Brevibacterium Species 0.000 claims abstract description 8
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 claims abstract description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 8
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 8
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims abstract description 7
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 7
- 241000186216 Corynebacterium Species 0.000 claims abstract description 5
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960002173 citrulline Drugs 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 11
- 229960004441 tyrosine Drugs 0.000 claims description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- 229930182844 L-isoleucine Natural products 0.000 claims description 3
- 239000004395 L-leucine Substances 0.000 claims description 3
- 235000019454 L-leucine Nutrition 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- 229960003136 leucine Drugs 0.000 claims description 3
- 229960002898 threonine Drugs 0.000 claims description 3
- 229960004295 valine Drugs 0.000 claims description 3
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims description 2
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 abstract description 29
- 238000012258 culturing Methods 0.000 abstract description 12
- -1 L-ILe Chemical compound 0.000 abstract description 10
- 239000001963 growth medium Substances 0.000 abstract description 7
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract description 5
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 abstract description 5
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 23
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 239000012531 culture fluid Substances 0.000 description 11
- 238000010438 heat treatment Methods 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000011218 seed culture Methods 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 239000012736 aqueous medium Substances 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 241000186226 Corynebacterium glutamicum Species 0.000 description 4
- 108010073771 Soybean Proteins Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000019710 soybean protein Nutrition 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZXFLCMHBSA-N 5-[(3ar,4r,6as)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1C(=O)N[C@H]2[C@@H](CCCCC(=O)O)SC[C@H]21 YBJHBAHKTGYVGT-ZXFLCMHBSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004470 DL Methionine Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 241000319304 [Brevibacterium] flavum Species 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000006109 methionine Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- VDWRUZRMNKZIAJ-UHFFFAOYSA-N tetradecylazanium;acetate Chemical compound CC(O)=O.CCCCCCCCCCCCCCN VDWRUZRMNKZIAJ-UHFFFAOYSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
ブレビバクテリウム属又はコリネバクテリウム属に属す
る中性アミノ酸産生変異株を培地に培養して中性アミノ
酸を発酵せしめる際に培地に界面活性剤を添加すること
によりL−グルタミン酸を同時に発酵せしめる中性アミ
ノ酸とグルタミン酸との同時発酵生産法に関する。Detailed Description of the Invention (Industrial Application Field) When fermenting neutral amino acids by culturing neutral amino acid-producing mutant strains belonging to the genus Brevibacterium or Corynebacterium in a medium, a surfactant is added to the medium. The present invention relates to a method for co-fermenting and producing a neutral amino acid and glutamic acid, in which L-glutamic acid is simultaneously fermented by adding L-glutamic acid.
(従来の技術)
従来、ブレビバクテリウム属又はコリネバクテリウム属
に属する微生物を使用してL−ロイシン(Leu) 、
L−イソロイシン(Il+、l 、 L−バリン
(Vat) 、 L−スレオニンITh・i、L−ト
リプトファン(Tap) 、 L−フェニルアラニン
(Phe) 、 L −チロシン(丁7+) 、
L−シトルリン(cit)及びL−ホモセリン(use
)などの中性アミノ酸が工業的に生産されている。(Prior art) Conventionally, L-leucine (Leu),
L-isoleucine (Il+, l, L-valine (Vat), L-threonine ITh・i, L-tryptophan (Tap), L-phenylalanine (Phe), L-tyrosine (D7+),
L-citrulline (cit) and L-homoserine (use
) and other neutral amino acids are industrially produced.
しかしながら、なお常に一層の生産コストの引下げが強
(望まれている。However, there is still a strong desire to further reduce production costs.
因みに、中性アミノ酸の発酵生産において界面活性剤を
培地に添加する例は知られているが、これは目的とする
単一のアミノ酸の収率を向上させる手段としてのもので
あって、L−グルタミン酸(Glu)の併産はみられな
い(特開昭62−288参照)。Incidentally, it is known that a surfactant is added to the culture medium in the fermentation production of neutral amino acids, but this is only as a means to improve the yield of a single target amino acid. Co-production of glutamic acid (Glu) is not observed (see JP-A-62-288).
(発明が解決しようとする課題)
発酵法による中性アミノ酸の生産において、Gluを併
産することによりアミノ酸をさらに工業的に安価に生産
する方法を提供することを目的とする。(Problems to be Solved by the Invention) An object of the present invention is to provide a method for industrially producing amino acids at a lower cost by co-producing Glu in the production of neutral amino acids by fermentation.
(課題を解決するための手段)
本発明者は、上記課題を解決すべく鋭意研究の結果、ブ
レビバクテリウム属又はコリネノくクテリウム属に属す
る、中性アミノ酸産生変異株を培地に培養して中性アミ
ノ酸を発酵せしめる際に培地に界面活性剤を添加すると
、Gluを同時に産生ずることを見出し、本発明をする
に至った。(Means for Solving the Problems) As a result of intensive research in order to solve the above problems, the present inventors cultivated a neutral amino acid-producing mutant strain belonging to the genus Brevibacterium or the genus Corynebacterium in a medium. The present inventors have discovered that when a surfactant is added to a culture medium during the fermentation of sexual amino acids, Glu is simultaneously produced, leading to the present invention.
すなわち、本発明は、ブレビバクテリウム属又はコリネ
バクテリウム属に属しかつL−ロイシン、L−イソロイ
シン、L−ノくリン、L−スレオニン、L−トリプトフ
ァン、L−フェニルアラニン、L−チロシン、L−シト
ルリン及びL−ホモセリンのいずれかの中性アミノ酸を
産生ずる変異株を培地に培養して該中性アミノ酸を発酵
生産する方法において該培地に界面活性剤を添加するこ
とを特徴とする中性アミノ酸とL−グルタミン酸とを同
時に発酵生産する方法に関する。That is, the present invention is directed to the use of plants belonging to the genus Brevibacterium or Corynebacterium and L-leucine, L-isoleucine, L-noculin, L-threonine, L-tryptophan, L-phenylalanine, L-tyrosine, L- A method for fermentatively producing a neutral amino acid by culturing a mutant strain that produces either citrulline or L-homoserine in a medium, which method comprises adding a surfactant to the medium. The present invention relates to a method for simultaneously fermenting and producing L-glutamic acid and L-glutamic acid.
本発明の方法によれば、単独に各々の中性アミノ酸を生
産するよりもグルタミン酸を併産する分だけ原料糖から
のアミノ酸生産の総量を増加させることができる。因み
に、経済的な観点より併産されるGluは、通常[1,
05g/c11以上蓄積することが望ましい。According to the method of the present invention, the total amount of amino acids produced from raw sugar can be increased by the co-production of glutamic acid, rather than producing each neutral amino acid individually. Incidentally, from an economic point of view, Glu that is co-produced is usually [1,
It is desirable to accumulate 05g/c11 or more.
以下、本発明方法を詳述する。The method of the present invention will be explained in detail below.
本発明方法の実施において、種培養、本培養及び必要に
応じての発酵液からの目的アミノ酸の単離などは全て従
来公知の各中性アミノ酸の発酵生産法によることができ
る。異なるのは、培地に界面活性剤を添加する点と発酵
液から必要により中性アミノ酸のみならずグルタミン酸
をも単離する点であるが、後者の点については、複数の
アミノ酸を含有する溶液からアミノ酸を混合物として又
はそれぞれ単独に分離すること、アミノ酸混合物を各ア
ミノ酸に分別することなどは従来当業者に周知の方法に
よることができるので、ここで特に説明を加える必要は
ないであろう。In carrying out the method of the present invention, the seed culture, main culture, isolation of the target amino acid from the fermentation liquid as needed, etc. can all be carried out by conventionally known fermentation production methods for each neutral amino acid. The difference is that a surfactant is added to the culture medium and that not only neutral amino acids but also glutamic acid are isolated from the fermentation solution if necessary. Separation of amino acids as a mixture or each individual amino acid, fractionation of an amino acid mixture into each amino acid, etc. can be carried out by methods conventionally known to those skilled in the art, so there is no need to add a special explanation here.
そこで、以下、界面活性剤の添加に関して説明する。Therefore, the addition of a surfactant will be explained below.
本発明方法で使用できる界面活性剤としては、例えば、
高級アルコールサルフェート、アルキルベンゼンスルフ
ォネート、アルキルフォスフェート、ジアルキルスルフ
オサクシネートなどのアニオン型界面活性剤、アルキル
アミン塩、第4級アンモニウム塩などのカチオン型界面
活性剤、ベタイン、ソミダゾリンベタインなどの両性イ
オン型界面活性剤、ポリオキシエチレンアルキルエステ
ル、ポリオキシエチレンソルビタンモノアルキルエステ
ルなどの非イオン型界面活性剤等を挙げることができる
。これらの界面活性剤は単独で使用してもよく又2種以
上を併用してもよい。Examples of surfactants that can be used in the method of the present invention include:
Anionic surfactants such as higher alcohol sulfates, alkylbenzene sulfonates, alkyl phosphates, dialkyl sulfosuccinates, cationic surfactants such as alkylamine salts and quaternary ammonium salts, betaine, somidazoline betaine, etc. Examples include amphoteric ionic surfactants, polyoxyethylene alkyl esters, and nonionic surfactants such as polyoxyethylene sorbitan monoalkyl esters. These surfactants may be used alone or in combination of two or more.
界面活性剤の培地への有効な添加使用量は、中性アミノ
酸産生菌、界面活性剤、種母接種量等により異なるが、
当業者であれば所与の場合において添加量を変えての簡
単な予備実験により極めて容易に定め得るが、通常0.
01〜5g/dlの範囲内にある。なお、後記実施例も
参照のこと。(実施例)
以下、実施例により本発明を更に説明する。The effective amount of surfactant to be added to the culture medium varies depending on the neutral amino acid-producing bacteria, the surfactant, the amount of seed inoculated, etc.
Usually 0.00, which a person skilled in the art can very easily determine in a given case by simple preliminary experiments with varying amounts of addition.
It is within the range of 01 to 5 g/dl. In addition, please also refer to Examples described later. (Example) Hereinafter, the present invention will be further explained with reference to Examples.
実施例1 (Lea)
第1表に示す組成の水性種母培地を500d容の振盪フ
ラスコに5Qd分注し、120℃で15分間加熱して滅
菌した。これにブレビバクテリウム・ラクトフェルメン
タム(B+evibacterinmlxclof!+
menuam) FERM P−1769を寒天斜面培
養物から1白金耳分取して接種し、31.5℃にて24
時間振盪培養して種培養液を得た。Example 1 (Lea) 5 Qd of an aqueous seed medium having the composition shown in Table 1 was dispensed into a 500 d shaking flask and sterilized by heating at 120° C. for 15 minutes. This is combined with Brevibacterium lactofermentum (B+evibacterinmlxclof!+
Menuam) FERM P-1769 was taken from an agar slant culture and inoculated by one platinum loop, and incubated at 31.5°C for 24 hours.
A seed culture solution was obtained by shaking culture for hours.
第1表
成 分 濃 度グルコ
ース 3 g/diKH2P04
G、1 gldiM g S O40
,04g / d IDL−メチオニン 40
■/dIFe++ 1
■/dIM n++ t
■/di「豆濃」 (全窒素として)200
■/diV B 1o、 2 wg / d 1ビオ
チン 0,05■/di尿素
0.3 g/djL−チロシン
40 ■/dirGD 113 J
*0.005m1/di’Ca CO35N / d
、 1
pH7,0(N a OH)
掌ポリオキシエチレンポリオキシプロピレングリセリン
エーテル
一方、第2表に示す組成の水性培地に界面活性剤として
ポリオキシエチレンソルビタンモノIくルミテートを0
.15g加えた主発酵培地を500m容肩付フラスコ1
0本にそれぞれ2Od宛分注し、120℃にて15分間
加熱して滅菌した。Table 1 Ingredients Concentration Glucose 3 g/diKH2P04
G, 1 gldiM g S O40
,04g/d IDL-Methionine 40
■/dIFe++ 1
■/dIM n++ t
■/di “Mameko” (as total nitrogen) 200
■/diV B 1o, 2 wg/d 1 biotin 0,05■/di urea
0.3 g/djL-tyrosine
40 ■/dirGD 113 J
*0.005m1/di'Ca CO35N/d
, 1 pH 7.0 (N a OH) Polyoxyethylene polyoxypropylene glycerin ether On the other hand, polyoxyethylene sorbitan mono I lumitate was added as a surfactant to an aqueous medium having the composition shown in Table 2.
.. Add 15g of main fermentation medium to 500m shoulder flask 1
The solution was dispensed into 2 Od bottles each and sterilized by heating at 120° C. for 15 minutes.
第2表
成 分 濃 度グルコ
ース 6 g/dj!ベ タ
イ ン 0
. 1 g / d IM g S Oi
、 o、 rJ 4 g / d
j!(NH4)2S04 4 g/dlビオチ
ン 0.05■/dlV B IO,3■
/ d I
DL−メチオニン 70 ■/dlKH2
PO40,1g/di
F e S 04 1 ”g
/ d IM n S O41tag / d 1「豆
濃」 (全窒素として) 625 ■/dirGD−
113J O,002d/alpH7,
0(KOH)
各フラスコの培地に予め乾熱滅菌した
C a CO3を5 g/clを夫々添加し、更に上記
種母培養液を3dずつ加えて31.5℃にて96時間培
養した。Table 2 Ingredients Concentration Glucose 6 g/dj! solid
In 0
.. 1 g/d IM g S Oi
, o, rJ 4 g/d
j! (NH4)2S04 4 g/dl Biotin 0.05■/dlV B IO,3■
/d I DL-Methionine 70 ■/dlKH2
PO40, 1g/di F e S 04 1”g
/ d IM n SO41tag / d 1 "Mameko" (as total nitrogen) 625 ■/dirGD-
113J O,002d/alpH7,
0 (KOH) 5 g/cl of C a CO 3 that had been dry heat sterilized in advance was added to the medium in each flask, and 3 d of the above seed culture solution was added and cultured at 31.5° C. for 96 hours.
各フラスコの培養液を合して培養液中のLea及びGl
uの蓄積量を定量したところ、それぞれ、0.54g/
dj!及び1.91 g / d lで、合計2.45
g/dlあった。Combine the culture fluids from each flask and combine the Lea and Gl in the culture fluid.
When the accumulated amount of u was quantified, it was 0.54 g/
dj! and 1.91 g/dl for a total of 2.45
g/dl.
比較のために界面活性剤を添加せずに培養した結果は、
LeLl及びGluの蓄積量は、それぞれ、114g/
dl及びOg/di及びであって、Gluの併産はみら
れなかった。For comparison, the results of culturing without adding surfactant are as follows.
The accumulated amount of LeLl and Glu is 114g/
dl and Og/di, and no co-production of Glu was observed.
実施例2 (lit)
グルコースを炭素源として含有する第3表に示す組成の
水性培地に界面活性剤としてポリオキシプロピレンペン
タエリスリトールステアリレートをQ、lOg/d/添
加してIt!生産用培地を調製し、eHを7.2に調節
後、5[10m容の振盪フラスコ10本に夫々20d宛
分注し、115℃にて10分間加熱して滅菌した。Example 2 (lit) Polyoxypropylene pentaerythritol stearate was added as a surfactant to an aqueous medium containing glucose as a carbon source and having the composition shown in Table 3 to give It! A production medium was prepared, and after adjusting the eH to 7.2, it was dispensed into 10 shaking flasks of 5 [10 m capacity each for 20 d, and sterilized by heating at 115° C. for 10 minutes.
第3表
グルコース L5.Ogldi(NH4
)2SO41,Og/di
KH2PO40,15g/di
MgS0 ・7H200,04g/diF e S
0 ・4 H201,0”g / d j’Mn50
・4H201,O■/d1
サイアミン・塩酸塩 3(lG、fl R/dl
。Table 3 Glucose L5. Ogldi(NH4
)2SO41,Og/di KH2PO40,15g/di MgS0 ・7H200,04g/diF e S
0 ・4 H201,0”g/d j'Mn50
・4H201,O■/d1 Thiamine hydrochloride 3(lG, fl R/dl
.
大豆蛋白酸分解液 25.0 ■/di(全
窒素として)
ビオチン 5.01197di各フラスコの
培地に予め培養して得られたブレビバクテリウム−7ラ
バム(B+evibieterium!liwumlF
ERM BP−759を接種し、315℃にてグルコー
スが消失するまで振盪培養した。所要時間は約72時間
であった。Soybean protein acid decomposition solution 25.0 ■/di (as total nitrogen) Biotin 5.01197di
ERM BP-759 was inoculated and cultured with shaking at 315°C until glucose disappeared. The time required was approximately 72 hours.
各フラスコの培養液を合して培養液中のllc及びGl
uの蓄積量を定量したところ、それぞれ、1.07g/
dl及び1.5(Ig/d/で、合計2.57g/dl
あった。Combine the culture fluids from each flask and
When the accumulated amount of u was quantified, it was 1.07 g/
dl and 1.5 (Ig/d/, total 2.57 g/dl
there were.
比較のために界面活性剤を添加せずに培養した結果は、
11ε及びGluの蓄積量は、それぞれ、1.8[1g
/dj!及びOg/d1及びであって、Gluの併産は
みられなかった。For comparison, the results of culturing without adding surfactant are as follows.
The accumulated amount of 11ε and Glu is 1.8[1g
/dj! and Og/d1, and no co-production of Glu was observed.
実施例3 (Vxl)
グルコースを炭素源として含有する第4表に示す水性培
地に界面活性剤として「カチオンMAJ(日本油脂社製
ミリスチルアミン酢酸塩)を0.20g/di添加して
L−バリン生産用培地を調製し、pHを7.0に調節後
、500td容の振盪フラスコ10本に夫々20−充分
注し、115℃にて10分間加熱して滅菌した。Example 3 (Vxl) 0.20 g/di of cationic MAJ (myristylamine acetate, manufactured by NOF Corporation) was added as a surfactant to an aqueous medium shown in Table 4 containing glucose as a carbon source to produce L-valine. After preparing a production medium and adjusting the pH to 7.0, 20-ml of the medium was poured into each of ten 500 td shaking flasks, and sterilized by heating at 115° C. for 10 minutes.
第4表
成 分 濃 度グルコ
ース 15.0 g / d 1(N
H4) 2So4 3.Og/dfKHPO
240,1g/di
MgSO−7F(200,(14g/d1Fe50
・4H201,fl tar/diM n S 0
・4 H201゜D ■/diサイアミン令塩酸塩
30.[l 119/di大豆蛋白酸分解液
80.0 ■/d1(全窒素として)
DL−メチオニン60.Ottg/diビオチン
5.OIII/di(炭酸カルシウム別殺菌添
加5.0 gldi)各フラスコの培地に予め培養し
て得られたブレビバクテリウム・ラクトフェルメンタム
(B+evibxcterium Iac+olerm
en+um) FERM P−1,845(FERM
HF−1061を接種し、31.5℃にてグルコースが
消費するまで振盪培養した。Table 4 Ingredients Concentration Glucose 15.0 g/d 1(N
H4) 2So4 3. Og/dfKHPO 240,1g/di MgSO-7F(200,(14g/d1Fe50
・4H201, fl tar/diM n S 0
・4 H201゜D ■/dithiamine dihydrochloride 30. [l 119/di soybean protein acid decomposition solution 80.0 ■/d1 (as total nitrogen) DL-methionine 60. Ottg/di biotin
5. Brevibacterium lactofermentum (B + evibxcterium Iac + olerm) obtained by pre-culture in the medium of each flask with OIII/di (sterilization addition of calcium carbonate 5.0 gldi)
en+um) FERM P-1,845 (FERM
HF-1061 was inoculated and cultured with shaking at 31.5°C until glucose was consumed.
培養液中のYal及びGluの蓄積量は、各フラスコの
培養液を合して定量したところ、それぞれ、0.87g
/di及び1.52g/dlで、合計2.39 g /
d1あった。The accumulated amounts of Yal and Glu in the culture solution were determined by combining the culture solutions of each flask, and found that each was 0.87 g.
/di and 1.52 g/dl for a total of 2.39 g/di.
There was d1.
比較のために界面活性剤を添加せずに培養した結果は、
■!1及びGluの蓄積量は、それぞれ、1.80g/
cl及びOg/d1及びであって、Gluの併産はみら
れなかった。For comparison, the results of culturing without adding surfactant are as follows.
■! The accumulated amount of 1 and Glu is 1.80g/
cl and Og/d1 and no co-production of Glu was observed.
実施例4 (Tb+)
第1表に示す組成の水性種母培地を使用して実施例1に
おける同様にしてブレビバクテリウム・フラバム(Br
ewibacje+ium [11vum)FERM
P−4164の種母培養液を得た。Example 4 (Tb+) Brevibacterium flavum (Br
ewibacje+ium [11vum)FERM
A seed culture solution of P-4164 was obtained.
一方、第5表に示す組成の水性培地に界面活性剤として
ポリオキシエチレンソルビタンモノパルミテートをQ、
15g加えた主発酵培地を500d容肩付フラスコlO
本にそれぞれ20H1宛分注し、115℃にて15分間
加熱して滅菌した。On the other hand, polyoxyethylene sorbitan monopalmitate was added as a surfactant to an aqueous medium having the composition shown in Table 5.
Add 15g of main fermentation medium to a 500d shoulder flask lO
Each volume was dispensed into 20H1 volumes and sterilized by heating at 115°C for 15 minutes.
第5表
成 分 濃 度グルコ
ース 6 g/diベタイン
0. l g / d IM g S O
4o、 04 g / d 1(NH4)2SO43g
/dl
ビオチン [05■/divB1
3 N/di。Table 5 Ingredients Concentration Glucose 6 g/diBetaine
0. l g / d IM g S O
4o, 04 g/d 1(NH4)2SO43g
/dl Biotin [05■/divB1
3 N/di.
KH2PO40,1g/di
F e S Oi、 1 ■
/ d IM n S Ot、
L ■/ d 1「豆濃」 (全窒素として)60
■/d/G D −1130,002d/ d
/pH7,4(KOH)
各フラスコの培地に予め乾熱滅菌した
C a CO3を5 g / d l夫々添加し、更に
上記種母培養液を3dずつ加えて31.5℃にて96時
間培養した。KH2PO40, 1g/di F e S Oi, 1 ■
/ d IM n S Ot,
L ■/d 1 “Mameko” (as total nitrogen) 60
■/d/G D -1130,002d/d
/ pH 7.4 (KOH) Add 5 g/dl of C a CO3, which had been dry heat sterilized in advance, to the medium in each flask, and then add 3 d of the above seed culture solution and culture at 31.5°C for 96 hours. did.
各フラスコの培養液を合して培養液中のThr及びGl
uの蓄積量を定量したところ、それぞれ、OJ1g/d
l及び1.03g/dlで、合計1.34g/d1あっ
た。Combine the culture fluids from each flask and add Thr and Gl in the culture fluid.
When the accumulated amount of u was quantified, each OJ1g/d
1 and 1.03 g/dl, for a total of 1.34 g/d1.
比較のために界面活性剤を添加せずに培養した結果は、
Thr及びGinの蓄積量は、それぞれ、0.95g/
cl’及びOg/dN及びであって、Gluの併産はみ
られなかった。For comparison, the results of culturing without adding surfactant are as follows.
The accumulated amounts of Thr and Gin are each 0.95g/
cl' and Og/dN and no co-occurrence of Glu was observed.
なお、発酵液から遠心分離によって菌体及びCa Co
3を除き、その上清を常法に従ってイオン交換樹脂で
処理してThrとGluとを各々得た。In addition, bacterial cells and CaCo are removed from the fermentation liquid by centrifugation.
Except for 3, the supernatant was treated with an ion exchange resin according to a conventional method to obtain Thr and Glu, respectively.
実施例5 (Phel
第1表に示す組成の水性種母培地を使用して実施例1に
おける同様にしてブレビバクテリウムeラクトフェルメ
ンタム(B+eyibxctt+iumlactoie
+mentum)ドERM l’−5417の種母培養
液を得た。Example 5 (Phel Brevibacterium e lactofermentum (B+eyibxctt+iumlactoie
A seed culture solution of ERM l'-5417 (+mentum) was obtained.
一方、第6表に示す水性培地に界面活性剤としてポリオ
キノエチレンソルビタンモノパルミテートを0.15g
加えた主発酵培地を500メ容肩付フラスコ10本にそ
れぞれ20〆宛分注し、110℃にて10分間加熱して
滅菌した。On the other hand, 0.15 g of polyoquinoethylene sorbitan monopalmitate was added as a surfactant to the aqueous medium shown in Table 6.
The added main fermentation medium was dispensed into 10 500-mem shoulder flasks, 20 times each, and sterilized by heating at 110° C. for 10 minutes.
第5表
成 分 濃 度グルコ
ース 6 g / d 1ベタイ
ン 0.1 g/dIMg S O4G
、 l g / d 1(NH4)2SO41g/d
l
ビオチン 005■/diVB、
2 ■/diDL−メチオニン
40 ■/cilKH2PO40,1g/
di
M n S 041 11g / d 1「味液J
5 M1/diL−チロシン
40 ■/di酢 酸
03 メ/diフマール
酸 1.2 g/di各フラスコの
培地に予め乾熱滅菌した
CaCO3を5 g/di夫々添加し、更に上記種母培
養液を3dずつ加えて31,5℃にて96時間培養した
。Table 5 Ingredients Concentration Glucose 6 g/d 1 Betaine 0.1 g/dIMg S O4G
, l g/d 1(NH4)2SO41g/d
l Biotin 005■/diVB,
2 ■/diDL-methionine
40 ■/cilKH2PO40,1g/
di M n S 041 11g / d 1 "Taste liquid J
5 M1/diL-tyrosine 40 ■/diacetic acid
03 Me/di fumaric acid 1.2 g/di 5 g/di of CaCO3, which had been dry heat sterilized in advance, was added to the medium in each flask, and the above seed culture solution was added in 3 d portions at 96° C. at 31.5°C. Cultured for hours.
各フラスコの培養液を合して培養液中のPhe及びGI
+の蓄積量を定量したところ、それぞれ、IJOg/d
j及び0.10g/dJで、合計1.40g/diあっ
た。Phe and GI in the culture solution were combined by combining the culture solutions of each flask.
When the accumulated amount of + was quantified, IJOg/d
j and 0.10 g/dJ, for a total of 1.40 g/di.
比較のために界面活性剤を添加せずに培養した結果は、
Pbe及びGluの蓄積量は、それぞれ、1.30g/
d/及びOg / d /及びであって、Glaの併産
はみられなかった。For comparison, the results of culturing without adding surfactant are as follows.
The accumulated amount of Pbe and Glu is 1.30g/each.
d/ and Og/d/, and no co-production of Gla was observed.
実施例6 (TYr)
第7表に示す組成の水性種母培地を5OOd容の振盪フ
ラスコに50d分注し、110℃にて5分間加熱して滅
菌した後、コリネバクテリウム・グルタミクム(Cor
ynebscterium glujxrAicam)
FERMP−5836を接種し31.5℃で16時間
振盪培養を行い種母培養液を得た。Example 6 (TYr) An aqueous seed medium having the composition shown in Table 7 was dispensed for 50 days into a 5OOd volume shaking flask, and after sterilization by heating at 110°C for 5 minutes, Corynebacterium glutamicum (Cor.
ynebscterium glujxrAicam)
FERMP-5836 was inoculated and cultured with shaking at 31.5°C for 16 hours to obtain a seed mother culture.
第7表培地組成
一方、同じく第7表に示す組成の水性主発酵培地を50
0ge容肩付フラスコ10本に夫々20d宛分注し、界
面活性剤としてポリオキシエチレンソルビタンモノパル
ミテートを0.15g/dl添加し、115℃にて15
分間加熱して滅菌した後、各フラスコの培地に上記種母
培養液を3d宛加えて31.5℃にて96時間培養した
。Table 7 Medium composition On the other hand, an aqueous main fermentation medium having the composition also shown in Table 7 was used at 50%
Dispense 20 d into 10 0 ge capacity shoulder flasks, add 0.15 g/dl of polyoxyethylene sorbitan monopalmitate as a surfactant, and add 0.15 g/dl of polyoxyethylene sorbitan monopalmitate as a surfactant.
After sterilizing by heating for 3 minutes, 3 d of the above seed culture solution was added to the medium in each flask and cultured at 31.5° C. for 96 hours.
各フラスコの培養液を合して培養液中のTH及びGla
の蓄積量を定量したところ、それぞれ、0.70g/d
j!及び0.25g/d1で、合計0.95g/dZあ
った。Combine the culture fluids from each flask and add TH and Gla in the culture fluid.
When the accumulated amount of each was quantified, it was 0.70 g/d.
j! and 0.25 g/d1, for a total of 0.95 g/dZ.
比較のために界面活性剤を添加せずに培養した結果は、
T7を及びGluの蓄積量は、それぞれ、0、78 g
/ d j及びOg/d1及びであって、GIOの併
産はみられなかった。For comparison, the results of culturing without adding surfactant are as follows.
The accumulated amounts of T7 and Glu were 0 and 78 g, respectively.
/ d j and Og/d1 and no co-production of GIO was observed.
実施例7 (Cil
グルコース 3g / di 、 K H2P O4
G、 Ig/df、Mg50 ・7 H20G 、
04 g / d ’ 。Example 7 (Cil Glucose 3g/di, K H2P O4
G, Ig/df, Mg50 ・7 H20G,
04 g/d'.
Fe50 ・7H201,0■/djl、MnSO4
・4H201,G■/d1.尿素0.3g/dl、大豆
蛋白酸加水分解液を全窒素として60■/di 。Fe50 ・7H201,0■/djl, MnSO4
・4H201, G■/d1. Urea 0.3g/dl, soybean protein acid hydrolyzate 60μ/di as total nitrogen.
サイアミン・HCl30γ/di 、 ビオチン20
γ/diを含む水性種母培地をpH6,0に調節し、そ
の50Idを500d容肩付フラスコに入れ、加熱殺菌
した。Thiamine/HCl30γ/di, biotin20
An aqueous seed medium containing γ/di was adjusted to pH 6.0, and the 50Id was placed in a 500 d shoulder flask and sterilized by heat.
これにコリネバクテリウム・グルタミクム(Cor7n
eb*c+e+iom glulamicum) FE
RM P−5643を接種し、31.5℃に保ちつつ、
13時間振盪培養して種母培養液を得た。In addition to this, Corynebacterium glutamicum (Cor7n
eb*c+e+iom glulamicum) FE
Inoculated with RM P-5643 and kept at 31.5°C,
A seed mother culture solution was obtained by culturing with shaking for 13 hours.
一方、グルコース13g/dl KH2PO40、Ig
/ di 、 M g S 0 ・7 H20o、
04 g /d l 、 F e S 0 ・7
H20t、 Qmg / d l 。On the other hand, glucose 13g/dl KH2PO40, Ig
/ di , M g S 0 ・7 H20o,
04 g/dl, F e S 0 ・7
H20t, Qmg/dl.
Mn S 0 ・4 H201,0■/ di 、硫
安3.0g7di 、大豆蛋白酸加水分解液を全窒素と
して65■/dl、 サイアミン・HC/20γ/d1
.ビオチン10γ/di、L−アルギニン70■/dl
を含むpH7,0に調節した水性培地に界面活性剤とし
てポリオキシプロピレンエリスリトールジミリステート
を0.15g/dl加えた培地を500d容の振盪フラ
スコ10本に夫々20dl宛分注し、115℃にて10
分間加熱して滅菌した。Mn S 0 ・4 H201,0■/di, ammonium sulfate 3.0g7di, soybean protein acid hydrolyzate as total nitrogen 65■/dl, thiamine・HC/20γ/d1
.. Biotin 10γ/di, L-arginine 70■/dl
A medium prepared by adding 0.15 g/dl of polyoxypropylene erythritol dimyristate as a surfactant to an aqueous medium adjusted to pH 7.0 and containing 20 dl of the medium was dispensed into ten 500 d shaking flasks, and heated to 115°C. te10
Sterilize by heating for minutes.
各フラスコの培地に上記種母培養液を3dずつ加え、3
1.5℃にてグルコースが消失するまで振盪培養した。Add 3 d of the above seed culture solution to the medium in each flask,
Shaking culture was carried out at 1.5°C until glucose disappeared.
所要時間は約96時間であった。The time required was approximately 96 hours.
各フラスコの培養液を合して培養液中のCil及びGl
uの蓄積量を定量したところ、それぞれ、。Combine the culture fluids from each flask and add Cil and Gl in the culture fluid.
When the amount of u accumulated was quantified, the results were as follows.
0.71g/d/及び0.71g/dAで、合計2.4
2 g /dlあった。0.71g/d/ and 0.71g/dA, total 2.4
It was 2 g/dl.
比較のために界面活性剤を添加せずに培養した結果は、
Cil及びGloの蓄積量は、それぞれ、1.76g/
dl及びOg / d l及びであって、Gluの併産
はみられなかった。For comparison, the results of culturing without adding surfactant are as follows.
The accumulated amounts of Cil and Glo were each 1.76g/
dl and Og/dl and no co-production of Glu was observed.
実施例8 (Trp)
第8表に示す組成の水性種母借地を50(ld容の振盪
フラスコに20d分注し、 115℃にて10分間加熱
して滅菌した後、ブレビバクテリウム・フラバム(B+
evibacte+iI1m flsvum)FERM
P−2238を接種して30℃で24時間振盪培養を
行い種母培養液を得た。Example 8 (Trp) An aqueous seed matrix having the composition shown in Table 8 was dispensed for 20 days into a shaking flask having a volume of 50 (20 mL), and after sterilization by heating at 115° C. for 10 minutes, Brevibacterium flavum ( B+
evibacte+iI1m flsvum)FERM
P-2238 was inoculated and cultured with shaking at 30°C for 24 hours to obtain a seed culture.
第8表
一方、同じく第8表に示す組成の水性主発酵培地を50
0m容肩付フラスコ10本に夫々20d宛分注し、界面
活性剤としてポリオキシエチレンソルビタンモノパルミ
テート0.20g/dA添加し、115℃にて10分間
加熱して滅菌した後、各フラスコの培地に上記種母培養
液を3d宛加えて30℃で72時間培養した。Table 8 On the other hand, 50% of the aqueous main fermentation medium having the composition shown in Table 8
Dispense 20 d each into 10 0 m capacity shoulder flasks, add 0.20 g/dA of polyoxyethylene sorbitan monopalmitate as a surfactant, and sterilize by heating at 115°C for 10 minutes. The above seed mother culture solution was added to the medium for 3 days and cultured at 30°C for 72 hours.
各フラスコの培養液を合して培養液中のTrp及びGl
uの蓄積量を定量したところ、それぞれ020g/dl
及び0.12g/d12で、合計0.32g/d1あっ
た。Combine the culture fluids from each flask and add Trp and Gl in the culture fluid.
When the accumulated amount of u was quantified, it was 020 g/dl, respectively.
and 0.12 g/d12, for a total of 0.32 g/d1.
比較のために界面活性剤を添加せずに培養した結果は、
Tap及びGluの蓄積量は、それぞれ0゜25g/d
12及びOg / diであって、Gluの併産はみら
れなかった。For comparison, the results of culturing without adding surfactant are as follows.
The accumulation amount of Tap and Glu is 0°25g/d, respectively.
12 and Og/di, and no co-occurrence of Glu was observed.
(発明の効果)
本発明により、アミノ酸の生産コストが引下げられるこ
ととなった。(Effects of the Invention) The present invention has reduced the production cost of amino acids.
Claims (1)
に属しかつL−ロイシン、L−イソロイシン、L−バリ
ン、L−スレオニン、L−トリプトファン、L−フェニ
ルアラニン、L−チロシン、L−シトルリン及びL−ホ
モセリンのいずれかの中性アミノ酸を産生する変異株を
培地に培養して該中性アミノ酸を発酵生産する方法にお
いて該培地に界面活性剤を添加することを特徴とする中
性アミノ酸とL−グルタミン酸とを同時に発酵生産する
方法。(1) Belongs to the genus Brevibacterium or Corynebacterium and L-leucine, L-isoleucine, L-valine, L-threonine, L-tryptophan, L-phenylalanine, L-tyrosine, L-citrulline, and L-homoserine Neutral amino acids, L-glutamic acid, A method for simultaneously fermenting and producing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29840690A JPH04169187A (en) | 1990-11-02 | 1990-11-02 | Simultaneous fermentative production of neutral amino acid and glutamic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29840690A JPH04169187A (en) | 1990-11-02 | 1990-11-02 | Simultaneous fermentative production of neutral amino acid and glutamic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04169187A true JPH04169187A (en) | 1992-06-17 |
Family
ID=17859299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29840690A Pending JPH04169187A (en) | 1990-11-02 | 1990-11-02 | Simultaneous fermentative production of neutral amino acid and glutamic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04169187A (en) |
-
1990
- 1990-11-02 JP JP29840690A patent/JPH04169187A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5494808A (en) | Defined medium OMPC fermentation process | |
JPH02186994A (en) | Production of l-amino acid by fermentation | |
JPH02186995A (en) | Production of l-arginine by fermentation method | |
JPS6115695A (en) | Preparation of l-isoleucine by fermentation method | |
JP3008565B2 (en) | Method for producing L-glutamic acid by fermentation method | |
JPH04169187A (en) | Simultaneous fermentative production of neutral amino acid and glutamic acid | |
JPH02283290A (en) | Production of l-ornithine by fermentation method | |
JPH04166092A (en) | Production of l-lysine by fermentation | |
JPS63258588A (en) | Production of l-valine by fermentation | |
KR0136719B1 (en) | Method for concurrent fermentation of basic amino acid and acidic amino acid | |
JPS5894391A (en) | Preparation of l-tryptophan by fermentation | |
JPS61128897A (en) | Production of l-phenylalanine by fermentation method | |
JP2817228B2 (en) | Method for producing L-glutamic acid | |
RU2241036C2 (en) | Method for preparing gamma-aminobutyric acid (gaba) | |
JPS6078590A (en) | Preparation of l-phenylalanine by fermentation | |
JPS6296094A (en) | Production of l-glutamic acid by fermentation | |
SU526295A3 (en) | Method for producing lysine | |
RU2061037C1 (en) | Nutrient medium for bifidobacterium and lactobacterium biomass accumulating | |
JPS58158194A (en) | Preparation of l-phenylalanine by fermentation process | |
KR0144641B1 (en) | Preparation process of l-leucine by fermentaion | |
KR920009542B1 (en) | Method for producing l-aminoacid | |
JPS6324896A (en) | Production of l-glutamic acid by fermentation | |
JPH0692A (en) | Production of l-arginine by fermentation method | |
JPS5816691A (en) | Preparation of l-lysine | |
JPH055476B2 (en) |